Compass Therapeutics (CMPX) Prepaid Assets (2019 - 2026)
Compass Therapeutics recorded quarterly Prepaid Assets of $1.0 million in Q1 2026, up 9.53% quarter-over-quarter from $913000.0 in Q4 2025, and down 91.31% year-over-year from $11.5 million in Q1 2025.
Compass Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 91.31% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 91.31% YoY), while the FY2025 annual figure was $913000.0, down 84.86% from the prior year.
- Prepaid Assets came in at $1.0 million for Q1 2026 at Compass Therapeutics, up from $913000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $11.5 million in Q1 2025 to a low of $913000.0 in Q4 2025.
- A 5-year average of $4.5 million and a median of $3.9 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 388.54% in 2025 and tumbled 91.31% in 2026, its largest moves.
- Compass Therapeutics' Prepaid Assets stood at $8.2 million in 2022, then plunged by 82.64% to $1.4 million in 2023, then surged by 324.58% to $6.0 million in 2024, then sank by 84.86% to $913000.0 in 2025, then climbed by 9.53% to $1.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.0 million, $913000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 913,000.00 |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 5.25 Mn |
| Mar 31, 2025 | 11.51 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 6.52 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Mar 31, 2021 | 1.95 Mn |
| Dec 31, 2020 | 3.13 Mn |
| Sep 30, 2020 | 2.31 Mn |
| Jun 30, 2020 | 1.92 Mn |
| Dec 31, 2019 | 935,000.00 |